Advertisement

---

ALEXZA PHARMACEUTICALS, INC.

Alexza Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference

[2013-07-01] -


Michael S. Holfinger, PhD, Joins Alexza Pharmaceuticals as Vice President, Manufacturing & Global Supply Chain Management

[2013-06-25] -


Alexza Reports 2013 First Quarter Financial Results

[2013-05-14] - Management to Review Results and Provide Business Update in Conference Call Scheduled Today for 5:00 p.m. Eastern Time


Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S.

[2013-05-08] - Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder


Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE® in the U.S.

[2013-05-08] - Call Scheduled Today for 9:00 a.m. Eastern Time


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers